The Effect of Non-Surgical Periodontal Therapy on Glycemic Control and Bacterial Levels in a Mexican-American Population With Type 2 Diabetes
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · May 20, 2010
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 18 years old
- • Diagnosed type 2 diabetes mellitus
- • Existence of moderate to severe periodontitis as defined by the American Academy of Periodontology
- • In good general health - able to undergo the proposed therapy without compromise to existing health
- • Demonstrated ability to read and understand written Spanish or English without the aid of ad-hoc interpretation by a third party
- • Demonstrated ability to understand the proposed therapy and possible outcome
- • Demonstrated willingness to comply with all protocol requirements as outlined in the informed consent document
- • Willingness/ability to sign an informed consent document for their own inclusion in the study
- • Hispanic origin as confirmed by patient records
- Exclusion Criteria:
- • Pregnancy at the time of enrollment (Pregnancy test is required for female study participants of child-bearing potential.)
- • Use of antibiotics within last 3 months
- • Immunocompromised health status
- • Other medical conditions that represent a threat to life
- • Osteoporosis
- • Biphosphonates, corticosteroids or behavior alteration medications
- • Historical abuse of alcohol or drugs
- • Use of cigarettes/tobacco products within the past 12 months
- • Mental diseases
- • Any other oral pathology that compromise the patient's medical status
- • Diagnosed type 1 diabetes mellitus (Information will be obtained from the medical records)
About The University Of Texas Health Science Center, Houston
The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Isabel C Gay, DDS, MS
Principal Investigator
University of Texas Health Science Center Dental Branch
James Katancik, DDS, PhD
Study Chair
University of Texas Health Science Center at Houston Dental Branch
Gena Tribble, PhD
Study Director
University of Texas Health science Center Houston Dental Branch
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials